topotecan has been researched along with Lymphoma, Mantle-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, WC; Fu, K; Golla, RM; Greiner, TC; Ji, M; Li, M; McKeithan, TW; Shen, Y; Yan, Y | 1 |
| D'Orazio, A; Gibson, AD | 1 |
2 other study(ies) available for topotecan and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Topics: Ataxia Telangiectasia Mutated Proteins; BRCA2 Protein; Cell Cycle Proteins; DNA Breaks, Single-Stranded; DNA Repair; DNA-Binding Proteins; Drug Resistance, Neoplasm; Gamma Rays; Humans; Lymphoma, Mantle-Cell; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; RNA, Small Interfering; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2012 |
VIII International Conference on malignant lymphoma. June 12-15, 2002 Lugano, Switzerland.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Paclitaxel; Prednisone; Rituximab; Time Factors; Topotecan; Treatment Outcome; Vincristine | 2002 |